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Some evidence suggests that a variety of genetic factors contributed in pathogenesis of the preeclampsia. The aim of this study
was to assess the association between the angiotensin-converting enzyme (ACE) I/D and angiotensin II type1 receptor A1166C
polymorphisms with preeclampsia. This study was performed in 125 preeclamptic pregnant women and 132 controls. The I/D
Polymorphism of the ACE gene was assessed by polymerase chain reaction and the A1166C Polymorphism of the AT1R gene
was determined by restriction fragment length polymorphism. The genotype and allele frequencies of I/D polymorphism diﬀered
between two groups. The risk of preeclampsia was 3.2-fold in pregnant women with D allele (OR, 3.2 [95% CI, 1.1 to 3.8];
P = 0.01). The distribution of the AT1R gene A1166C polymorphism was similar in aﬀected and control groups. Our results
supported that presence of the I/D polymorphism of ACE gene is a marker for the increased risk of preeclampsia.
1.Introduction
Preeclampsia is a potentially serious condition of pregnancy
that covers almost 10% of pregnancies in the developing
countries. It has a severe morbidity and mortality risk
for both mother and child [1]. The exact etiology of this
diseaseisstillunknownbutseveralpathophysiologicalmech-
anisms have been suggested for preeclampsia. These include
endothelial dysfunction, inﬂammatory pathway, oxidative
stress, activation of thrombosis, and the renin-angiotensin
system [2].
Various genetic and environmental factors have been
known that contribute in pathogenesis of this disorder [3].
Ward and Lindheimer reported an incident risk of 20 to
40 percent for daughters of preeclamptic mothers, 11 to
37 percent for sisters of preeclamptic women, and 22 to
47 percent in twin studies for preeclampsia [4]. Several
studies have tried to demonstrate or refute the role of rennin
angiotensin system genes as candidates for the development
of preeclampsia. The circulating renin-angiotensin system
(RAS) is an important pathway that regulates blood pressure
and electrolyte balance [1].
In low blood pressure and low circulating sodium chlo-
ride, the renin enzyme synthesized by juxtaglomerular cells
oftheaﬀerentrenalarteriolesofkidneyandreleasedinblood
[5]. Renin cleaves angiotensinogen, to angiotensin-1 (ANG
I), a ten-amino-acid peptide. ANG I is an inactive peptide
but is cleaved by angiotensin-converting enzyme (ACE) to
the biologically active angiotensin-II (8 amino acid). The
angiotensin converting enzyme (ACE; EC 3.4.15.1) is a
dipeptidyl carboxypeptidase that is encoded by the ACE
gene. This gene is located on chromosome 17q23 and
contains 26 exons and 25 introns [6]. Two isoforms of
angiotensin receptors exist in diﬀerent tissues: AT1 and AT2.
They are from seven transmembrane G-protein-coupled
receptor family. ANG II exerts most of its eﬀects via the2 Journal of Biomedicine and Biotechnology
activation of AT1 receptors which are expressed in vascular
smooth muscle cells and adrenal glands, among others. This
receptor is coupled to the Gq protein to increase intracellular
calcium [5].
Therefore we investigated the relationship of two com-
mon polymorphisms of the rennin-angiotensin system:
intron 16 of the ACE gene on chromosome 17 and the A-to-
C polymorphism in the 3  untranslated region at nucleotide
1166 of the AT2R1 gene on chromosome 3.
2.MaterialsandMethods
2.1. Study Subjects. The project was approved by the
Zahedan University of Medical Sciences Ethics Committee.
This cross-sectional study was performed in 125 preeclamp-
tic pregnant women and 132 healthy pregnant women
from January 2008 to February 2010. At the time of
admission, after written consent a verbal interview was
conducted to determine maternal age, gestational age, gra-
vidity, birth weight, family history of preeclampsia, history
of preeclampsia in previous pregnancies, and ethnicity.
Ethnicity was determined by self report. Preeclampsia was
deﬁned as increased blood pressure (≥140mmHg systolic or
≥90mmHg diastolic on 2 or more measurements at least 6h
apart) and with signiﬁcant proteinuria ≥0.3g/24hor ≥+1
on a urine dipstick in a woman after 20 weeks of gestation
[7].
Blood pressure was taken with the patient in an upright
position, after a 10-minute rest period with a mercury
sphygmomanometer. The right arm was used for the mea-
surement, and it was placed in a horizontal position at heart
level [8].
Exclusion criteria included twin or multiple pregnancies
or any evidence of previous medical disease. One hun-
dred thirty seven normotensive pregnant volunteers were
randomly recruited from the Obstetrics ward of Ali-Ebne-
Abitaleb Hospital who did not have any evidence of previous
medical illness.
2.2. DNA Analysis. Genomic DNA was extracted from
peripheral blood leukocytes by DNA isolation kit (Roche,
Germany). Two oligonucleotide primers, forward: 5 -CTG
GAG AGC CAC TCC CAT CCT TTC T-3  and reverse: 5 -
GGG ACG TGG CCA TCA CAT TCG TCA G-3  based on
theﬂankingsequencesoftheinsertion/deletionregiononthe
intron 16 of ACE gene were used to amplify the correspond-
ing DNA fragments by polymerase chain reaction (PCR)
[9]. The reaction was performed in a 25-μLﬁ n a lv o l u m e
and contained 25pmol of each primer, 0.1mmol of each
deoxynucleoside triphosphate (Fermentas, Lithuania), 1U
Taq DNA polymerase (Fermentas, Lithuania), 50mmol/L
KCl, 1.5mmol/L MgCl2, 10mmol/L Tris-HCl (PH = 8.3),
and 200ng of genomic DNA according to the protocol as
previously described except for the annealing step which
was at 60◦C[ 10]. The PCR products of two alleles of 490
and 190bp were electrophoresed in 2% agarose gels and
visualized by ethidium bromide staining. Due to the D allele
in heterozygous samples which are preferably proliferated,
every sample demonstrated to have DD genotype depending
on a second, independent PCR ampliﬁcation with a major
pair known as an addition which is particular sequence
described before. The feedback produced a 335-bp amplicon
just in the existence of an I allele and no product in homozy-
gous for DD [9].
For detection of A1166C polymorphism of the angi-
otensin II receptor AT1, two oligonucleotide primers (for-
ward) 5 -AAT GCT TGT AGC CAA AGT CAC CT-3  and
(reverse)5 -GGC TTTGCTTTGTCTTGTTG-3  were used
for ampliﬁcation the corresponding DNA fragment by the
p o l y m e r a s ec h a i nr e a c t i o n[ 11]. The reaction was performed
in a 25-μL ﬁnal volume and contained 30pmol of each
primer,0.1mmolofeachdeoxynucleosidetriphosphate(Fer-
mentas, Lithuania), 1U Taq DNA polymerase (Fermentas,
Lithuania), 50mmol/L KCl, 2.5mmol/L MgCl2, 10mmol/L
Tris-HCl (PH = 8.3), and 250ng of genomic DNA according
to the following protocol: initial denaturation at 94◦Cf o r
5min; 35 cycles of denaturation at 94◦C for 30sec, annealing
at 57◦C for 30sec, and extension at 72◦Cf o r1 m i na n d
30sec; and ﬁnal extension at 72◦C for 5min. The 856pb
PCR fragments were digested with Dde1 restriction enzyme
(Fermentas, Lithuania) for 16h at 37◦C. The wild-type allele
(A allele) has one Dde1 cleavage site and digested to 600 and
256bp fragments, whereas the mutant allele (C allele) has
two Dde1 cleavage site and 256bp fragment is cleaved to 146
and 110bp fragments too. Digested samples were separated
by electrophoresis on a 2% agarose gel and visualized by
ethidium bromide staining.
2.3. Statistical Analyses. All statistical analyses were per-
formed with SPSS V-11.5. The diﬀerences between groups
were examined by χ2 test or an independent Student’s t-
test whenever appropriate. Allele frequencies were estimated
by the gene counting method. The frequencies of the alleles
and genotypes were compared between patients and control
groups by the χ2 test when appropriate. The odds ratio
(OR) and 95% conﬁdence intervals (CI) were also estimated.
The χ2 test was used for deviation of genotype distribu-
tion from Hardy-Weinberg equilibrium. Logistic regression
analysis was employed to determine the relations of gene
polymorphisms and other risk factors with preeclampsia.
3. Results
For the case control study, 125 preeclamptic women and
132 healthy pregnant women were enrolled the clinical and
biochemical parameters of the controls and preeclamptic
subjects are shown in Table 1.
There was no signiﬁcant diﬀerence between two groups
for maternal age and family history of preeclampsia.
As expected gestational age was signiﬁcantly lower and
systolicanddiastolicbloodpressure,primiparity,andhistory
of preeclampsia were signiﬁcantly higher in preeclamptic
women. Although birth weight was lower in preeclamptic
women, the diﬀerence was not signiﬁcant.
The frequencies of ethnic groups (Persian, Balooch, and
Afghan) were signiﬁcantly diﬀerent between preeclamptic
women and controls (P = 0.03) and the risk of preeclampsiaJournal of Biomedicine and Biotechnology 3
Table 1: Demographic characteristics of preeclamptic patients and controls.
Preeclampsia
N = 125
Controls
N = 132
Odds ratio
(95% CI) P value χ2
Age (years) 27.2 ±7.82 6 .2 ±6.2N S
Gestational age (days) 256.2 ±25.4 267.5 ±19.8 0.002
Child birth weight (g) 2789 ±829 2955 ±646 NS
Diastolic blood pressure (mm Hg) 96 ±8.76 9 .2 ±8 0.0001
Systolic blood pressure (mm Hg) 151.7 ±14 110.7 ±9 0.0001
Primigravida n (%) 56 (45) 42 (32) 1.7 (1–2.9) 0.025 4.4
Family history of preeclampsia n (%) 47 (38) 42 (32) NS
History of preeclampsia n (%) 40 (32) 5 (4) 10.6 (3.5–32) 0.0001 23
Race n (%) 0.03 7.3
Persian 32 (26) 49 (37)
Balooch 55 (44) 61 (46)
Afghan 38 (30) 22 (17)
Persian + Balooch 87 (70) 110 (83) 2 (1.1–3.8) 0.019 4.8
Afghan 38 (30) 22 (17)
Table 2: Genotype and allele frequencies of I/D polymorphism of the ACE gene and A1166C polymorphism of the angiotensin II type-1
receptor in preeclamptic patients and controls.
Preeclampsia
N = 125
Controls
N = 132 χ2 P value Odds ratio
I/D polymorphism
II, n (%) 18 (14.5) 46 (35)
ID, n (%) 64 (51.5) 49 (37)
DD, n (%) 43 (34) 37 (28)
ID+DD (%) 107 (85.5) 86 (65) 14.4 0.0001 3.2 (1.7–5.9)
I( % ) 0 . 4 0 . 5 3
D( % ) 0 . 6 0 . 4 7
A1166C polymorphism
AA, n (%) 109 (87) 118 (89)
AC, n (%) 15 (12) 12 (9)
CC, n (%) 1 (1) 2 (2)
AC+CC (%) 16 (13) 14 (11) 0.3 0.36
A (%) 0.93 0.94
C (%) 0.07 0.06
was twofold in Afghan women in contrast to Persian and
Balooch women (OR, 2 [95% CI, 1.1 to 3.8]; P = 0.01).
Among the preeclamptic women, 20% had early onset
preeclampsia and 80% had late onset preeclampsia, also the
frequency of severe and mild preeclampsia was 76% and
24%, respectively.
Allele frequencies of I/D Polymorphism of ACE and
A1166C polymorphism of angiotensin II type-1 receptor
polymorphism were in Hardy Weinberg equilibrium in
preeclampsia group however control subjects are in Hardy-
Weinberg disequilibrium for both polymorphisms (P =
0.004 and P = 0.02, resp.).
The distribution of genotype and allele frequencies of
I/D polymorphism of angiotensin-converting enzyme and
A1166C polymorphism of angiotensin II type-1 receptor
(AT1R) gene were compared between preeclamptic patients
and controls (Table 2).
The frequencies of II, ID, and DD genotypes were 14.5,
51.5, and 34 percent in preeclamptic patients and 35, 37, and
38inhealthypregnantwomen,respectively.Thefrequencyof
D allele was 0.6 in preeclamptic patients and 0.47 in controls.
The risk of preeclampsia was 3.2-fold in pregnant women
withDallele(ID+DD)incontrasttocontrolwomenwithout
D allele (OR, 3.2 [95% CI, 1.1 to 3.8]; P = 0.01).
The distribution of the AT1R A1166C polymorphism
was similar in aﬀected and control groups. The genotype
frequencies for the control and preeclamptic women being
87, 12, and 1% and 89, 9, and 2% for the AA, AC, and
CC genotypes, respectively. Only three subjects with the CC
genotypewereidentiﬁed:twocontrolsubjectandonesubject4 Journal of Biomedicine and Biotechnology
Table 3: Multiple logistic regression analysis with forward stepwise selection (Wald).
Risk factors B S.E. Wald df Sig. Exp (B) 95% CI
Lower Upper
Afghan race 1.4 0.44 10.3 1 0.001 6.28 2.1 19
History of preeclampsia 2.7 0.57 21.9 1 0.0001 14.7 4.8 45
Primigravida 0.925 0.327 8 1 0.005 2.5 1.3 4.8
ID+DD genotype 1.1 0.367 8.7 1 0.003 2.95 1.4 6.1
Constant 0.36 0.36 1.01 1 0.314 1.4
with preeclampsia. The C allele frequencies of the AT1R
gene were 0.07 and 0.06 in control subjects and preeclamptic
women, respectively.
We did not ﬁnd any correlation between ACE and
AT1R gene polymorphisms and the onset and severity of
preeclampsia.AlsowedidnotobserveanydiﬀerencesinACE
and AT1R gene polymorphisms in diﬀerent races too.
There were no signiﬁcant diﬀerence in blood pressure
levels (SBP and DBP) between the subjects with the diﬀerent
genotypes of ACE I/D polymorphism.
Multiple regression analysis, revealed that Afghan race,
historyofpreeclampsia,gravity,andpresenceofDallelewere
independent risk factors of preeclampsia (Table 3).
4. Discussion
Preeclampsiaisamultifactorialdisorderthatresultsfromthe
interaction of multiple environmental and genetic factors.
The precise cause of preeclampsia has not been determined
but numerous and extensive analysis in animal models and
human studies have been performed to ﬁnd the relation of
environmental and genetic factors with this disorder [6].
Several studies identiﬁed various candidate genes in-
volved in high blood pressure of pregnancy and preeclamp-
sia. Special attention has been paid to study on genes of
the rennin-angiotensin system (RAS) because the synthesis
of angiotensin II. Angiotensin converting enzyme converts
inactive angiotensin I to vasoactive angiotensin II, therefore
this enzyme is an important member of RAS and plays
a key role in blood pressure regulation and electrolyte
balance. Angiotensin II exerts its most actions via AT1R
[12]. There are incompatible results on the relationship of
ACEactivityandpreeclampsia.PlasmaACEactivityhasbeen
associated with the insertion/deletion (I/D) polymorphism
in intron 16 of the ACE gene. There is evidence that
DD genotype is associated with higher plasma ACE levels,
whereas II genotype is associated with lower ACE levels and
IDgenotypewithmiddlelevels[9].Thereasonforthehigher
ACE activity in the D allele has assumed that the I allele
has a sequence like to a silencer sequence [13]. Therefore we
investigatedtherelationshipofpreeclampsiatotwocommon
polymorphisms of the rennin-angiotensin system: intron 16
I/D polymorphism of the ACE gene on chromosome 17
and the A-to-C polymorphism in the 3 -untranslated region
at nucleotide 1166 of the AT2R1 gene on chromosome 3
[9, 14].
In the present study we found that the ACE gene I/D
genotype and allele frequencies were diﬀerent between two
groups and D allele was more frequent in preeclamptic
womenthancontrols.AndinwomenwithDallele(DI+DD),
the risk of preeclampsia was 3.2-fold (OR, 3.2 [95% CI, 1.7
to 5.9]; P = 0.0001).
The results of our study are consistent with some but
not all previous studies of ACE I/D polymorphism and
preeclampsia in other countries. Zhu et al. and Zhou et
al. in two diﬀerent studies reported the association of ACE
I/D polymorphism and preeclampsia in Chinese women
and G¨ urd¨ ol et al. and Choi et al. reported the association
of ACE genotypes with preeclampsia in Turkey and Korea
too [13, 15–17]. Also Li et al. found that ACE gene I/D
polymorphism were associated with the severe proteinuria
andrenaldysfunctionseeninpreeclampsiaandpreeclamptic
patients carrying the D allele may be susceptible to renal
dysfunction in China [18].
Miˇ skovi´ c et al. showed a signiﬁcant association between
D allele frequency and risk of recurrent preeclampsia and
preterm delivery before 34 weeks of pregnancy in Croatia
[19].
Mand` o et al. reported that, the distribution of ACE
genotypes was diﬀerent in preeclamptic women and controls
in Italy. They conﬁrmed this result in mild preeclampsia,
whereas no signiﬁcance was found in severe preeclampsia.
They suggest that diﬀerent factors may lead to mild and
severe preeclampsia and ACE polymorphism playing a more
important role in the mild form [20]. Also Velloso et al.
suggested that the ACE DD genotype may be used as a
marker for susceptibility to preeclampsia in Brazil [21],
whereas Benedetto et al. revealed that the synergic eﬀect
of ACE I/D and other polymorphisms of renin-angiotensin
system and eNOS may be a risk factor for preeclampsia
[22].
In contrast several studies in diﬀerent countries did
not support the hypothesis about the association between
ACE I/D polymorphism and preeclampsia. Nalogowska-
Glosnicka et al. [23] in Poland, Heiskanen et al. [24]i n
Finland, Gal˜ ao et al. [25] in Brazil, Kim et al. [26]i n
Korea, Roberts et al. [27] in South Africa, Kobashi et al.
[28] in Japan showed no association between angiotensin-
converting enzyme polymorphism and preeclampsia.
Serrano et al. revealed a null association between the
ACE-I/DvariantandpreeclampsiariskinColombiatoo[29].
In a recent study Aggarwal et al. did not ﬁnd any associationJournal of Biomedicine and Biotechnology 5
between ACE gene polymorphism and hypertensive disor-
ders of pregnancy in north India [30].
Medica et al. performed a systematic research on 10 case-
control studies about intron 16 I/D polymorphism of ACE
gene-containing 1121 patients and 1361 controls. When they
c o m p a r e dh o m o z y g o u sc a r r i e r so fDv a r i a n tp l u sI Dh e t -
erozygotes (DD+ID) versus homozygous carriers of I variant
(II), the odds ratio was 1.11 (95% CI; .91, 1.36). Whereas
when they compared homozygous D variant carriers (D/D)
versus heterozygous plus homozygous I variant (ID + II)
individuals (recessive model), the odds ratio was OR 1.51
(95% CI 1.17, 1.94); therefore they reported that single
ACE I/D polymorphism did not have a major eﬀect on
preeclampsia, but statistical signiﬁcance was demonstrated
when the polymorphism was considered under the recessive
model [31]. The results of present study showed the relation
ofthispolymorphismwithpreeclampsiaindominantmodel.
This discrepancy in diﬀerent studies is common and is
due to diﬀerent races, study volume, preeclampsia criteria,
and other factors, however considering meta analysis study,
it is more probable that the small study volume is the most
important reason of this discrepancy.
In this study, we found no evidence of association
between the polymorphic variants, the AT2R1 gene, and
preeclampsia. The C allele frequency of the AT1R gene was
0.06 and 0.07 in control subjects and preeclamptic women,
respectively.
There are a few studies about the association of AT2R1
polymorphism and preeclampsia. Li et al. reported that
the frequency of genotypes of the AT1R gene was similar
in preeclampsia and normal pregnancy [18]. Morgan et
al. did not found any association between AT2R1 A1166C
polymorphism with preeclampsia in UK [32]. But Hu et
al. reported that the frequency of variants (AC, CC) of
A1166C polymorphism of AT1R gene in pregnancy-induced
hypertension (PIH) (20.5%) was signiﬁcantly higher than
that of control subjects (7.4%) [33]. Seremak-Mrozikiewicz
et al. revealed that presence of A1166C polymorphism is a
risk factor for the development of PIH too [34].
In an other study Bouba et al. found that the women
with preeclampsia and TT genotype of angiotensinogen had
more frequently the DD genotype of ACE or the 1166C allele
of AT1R than the control group and reported a signiﬁcant
interaction between the genes [35].
We also did not ﬁnd any signiﬁcant diﬀerence in rare
allele’s frequency of polymorphisms between three ethnic
groups (Persian, Balooch, and Afghan), but we observed
high prevalence of preeclampsia in Afghan women (OR =
2 95% CI: 1.1–3.8). Because ethnicity have an important
role in association studies, further studies with large samples
must be done especially on Afghan pregnant women in these
polymorphisms and other gene polymorphisms too.
In conclusion, we observed the association between
I/D polymorphism of ACE gene and preeclampsia, but
no relation was found between A1166C polymorphism of
AT1R gene and preeclampsia. We found that Afghan race,
history of preeclampsia; gravity and presence of D allele were
independent risk factors of preeclampsia.
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